A lot is happening in the bioeconomy, from AI to scale-up innovation to new government policies. For this episode, host Fiona Mischel sat down with renowned bioeconomy leader Alexander Titus to help sort out the hype from reality and see opportunities where most might see pitfalls.

In this episode of The Inside Track, Jeff Buguliskis, Director of Content at SynbioBeta, focuses on the intersection of AI & Digital Biology and Biomanufacturing Scale-Up. Joined by esteemed guests Shelby Newsad, an investor at Compound with a broad background in biology and healthcare, and Shannon Hall, CEO and Co-founder of Pow.bio, a pioneering Berkeley-based startup in precision fermentation, the conversation navigates through the potent fusion of AI and biotech. With Shelby's insights on AI's pivotal role and Shannon's firsthand experiences in leveraging AI for biomanufacturing, the dialogue scrutinizes the promises and perils of these technologies. From ethical dilemmas to regulatory hurdles, the podcast explores the multifaceted landscape of synthetic biology. We’ll also hear what Shannon and Shelby are most excited about for the upcoming SynBioBeta 2024 conference. Join us as we unravel the future of biotech innovation.

Tune in to this episode of "The Inside Track," a podcast series that examines the intersection of synthetic biology with capital markets and consumer products. Hosted by Jeff Buguliskis, Director of Content for SynbioBeta, this episode engages with Amanda Cashin, a Life Science Investor and Entrepreneur, and Erin Kim, Principal Owner of Erin Kim Consulting. The discussion focuses on the relationship between capital investment and the development of consumer products within the synthetic biology sector. They cover topics such as the growth of synthetic biology investments, the effects of economic conditions on capital flows, and recent innovations in consumer products. Additionally, the conversation includes insights on integrating consumer product innovation with capital investment, the influence of public perception, and the upcoming SynBioBeta conference. Join us for a detailed dialogue on the critical elements shaping the synthetic biology landscape.